866-997-4948(US-Canada Toll Free)

EMEA (Europe, Middle East and Africa) Flu Vaccine Market Report 2017

Published By :

QYResearch

Published Date : Jun 2017

Category :

Pharmaceutical

No. of Pages : 112 Pages

In this report, the EMEA Flu Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Flu Vaccine for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Flu Vaccine market competition by top manufacturers/players, with Flu Vaccine sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
Sanofi-pasteur
Novartis
GSK
Abbott
Pfizer
CSL
Hualan Bio
Changchun Bio
Alephbio
Sinovac
CS Vaccine
Tianyuan Bio
Tiantan Bio
Siobp

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
Whole Virus Vaccines
Split Virus Vaccines
Subunit Or Surface Antigen Vaccines
Live Attenuated (Cold-Adapted) Virus Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Flu Vaccine for each application, including
For Children (6 months to 3 years old)
For Adult and Children over 3 years

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

EMEA (Europe, Middle East and Africa) Flu Vaccine Market Report 2017
1 Flu Vaccine Overview
1.1 Product Overview and Scope of Flu Vaccine
1.2 Classification of Flu Vaccine
1.2.1 EMEA Flu Vaccine Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Flu Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Whole Virus Vaccines
1.2.4 Split Virus Vaccines
1.2.5 Subunit Or Surface Antigen Vaccines
1.2.6 Live Attenuated (Cold-Adapted) Virus Vaccines
1.3 EMEA Flu Vaccine Market by Application/End Users
1.3.1 EMEA Flu Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 For Children (6 months to 3 years old)
1.3.3 For Adult and Children over 3 years
1.4 EMEA Flu Vaccine Market by Region
1.4.1 EMEA Flu Vaccine Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Flu Vaccine (2012-2022)
1.5.1 EMEA Flu Vaccine Sales and Growth Rate (2012-2022)
1.5.2 EMEA Flu Vaccine Revenue and Growth Rate (2012-2022)

2 EMEA Flu Vaccine Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Flu Vaccine Market Competition by Players/Manufacturers
2.1.1 EMEA Flu Vaccine Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Flu Vaccine Revenue and Share by Players (2012-2017)
2.1.3 EMEA Flu Vaccine Sale Price by Players (2012-2017)
2.2 EMEA Flu Vaccine (Volume and Value) by Type/Product Category
2.2.1 EMEA Flu Vaccine Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Flu Vaccine Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Flu Vaccine Sale Price by Type (2012-2017)
2.3 EMEA Flu Vaccine (Volume) by Application
2.4 EMEA Flu Vaccine (Volume and Value) by Region
2.4.1 EMEA Flu Vaccine Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Flu Vaccine Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Flu Vaccine Sales Price by Region (2012-2017)

3 Europe Flu Vaccine (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Flu Vaccine Sales and Value (2012-2017)
3.1.1 Europe Flu Vaccine Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Flu Vaccine Revenue and Growth Rate (2012-2017)
3.2 Europe Flu Vaccine Sales and Market Share by Type
3.3 Europe Flu Vaccine Sales and Market Share by Application
3.4 Europe Flu Vaccine Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Flu Vaccine Sales Volume by Countries (2012-2017)
3.4.2 Europe Flu Vaccine Revenue by Countries (2012-2017)
3.4.3 Germany Flu Vaccine Sales and Growth Rate (2012-2017)
3.4.4 France Flu Vaccine Sales and Growth Rate (2012-2017)
3.4.5 UK Flu Vaccine Sales and Growth Rate (2012-2017)
3.4.6 Russia Flu Vaccine Sales and Growth Rate (2012-2017)
3.4.7 Italy Flu Vaccine Sales and Growth Rate (2012-2017)
3.4.8 Benelux Flu Vaccine Sales and Growth Rate (2012-2017)

4 Middle East Flu Vaccine (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Flu Vaccine Sales and Value (2012-2017)
4.1.1 Middle East Flu Vaccine Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Flu Vaccine Revenue and Growth Rate (2012-2017)
4.2 Middle East Flu Vaccine Sales and Market Share by Type
4.3 Middle East Flu Vaccine Sales and Market Share by Application
4.4 Middle East Flu Vaccine Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Flu Vaccine Sales Volume by Countries (2012-2017)
4.4.2 Middle East Flu Vaccine Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Flu Vaccine Sales and Growth Rate (2012-2017)
4.4.4 Israel Flu Vaccine Sales and Growth Rate (2012-2017)
4.4.5 UAE Flu Vaccine Sales and Growth Rate (2012-2017)
4.4.6 Iran Flu Vaccine Sales and Growth Rate (2012-2017)

5 Africa Flu Vaccine (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Flu Vaccine Sales and Value (2012-2017)
5.1.1 Africa Flu Vaccine Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Flu Vaccine Revenue and Growth Rate (2012-2017)
5.2 Africa Flu Vaccine Sales and Market Share by Type
5.3 Africa Flu Vaccine Sales and Market Share by Application
5.4 Africa Flu Vaccine Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Flu Vaccine Sales Volume by Countries (2012-2017)
5.4.2 Africa Flu Vaccine Revenue by Countries (2012-2017)
5.4.3 South Africa Flu Vaccine Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Flu Vaccine Sales and Growth Rate (2012-2017)
5.4.5 Egypt Flu Vaccine Sales and Growth Rate (2012-2017)
5.4.6 Algeria Flu Vaccine Sales and Growth Rate (2012-2017)

6 EMEA Flu Vaccine Manufacturers/Players Profiles and Sales Data
6.1 Sanofi-pasteur
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Flu Vaccine Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Sanofi-pasteur Flu Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Novartis
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Flu Vaccine Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Novartis Flu Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 GSK
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Flu Vaccine Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 GSK Flu Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Abbott
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Flu Vaccine Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Abbott Flu Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Pfizer
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Flu Vaccine Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Pfizer Flu Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 CSL
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Flu Vaccine Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 CSL Flu Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Hualan Bio
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Flu Vaccine Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Hualan Bio Flu Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Changchun Bio
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Flu Vaccine Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Changchun Bio Flu Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Alephbio
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Flu Vaccine Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Alephbio Flu Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Sinovac
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Flu Vaccine Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Sinovac Flu Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 CS Vaccine
6.12 Tianyuan Bio
6.13 Tiantan Bio
6.14 Siobp

7 Flu Vaccine Manufacturing Cost Analysis
7.1 Flu Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Flu Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Flu Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Flu Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Flu Vaccine Market Forecast (2017-2022)
11.1 EMEA Flu Vaccine Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Flu Vaccine Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Flu Vaccine Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Flu Vaccine Price and Trend Forecast (2017-2022)
11.2 EMEA Flu Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Flu Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Flu Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Flu Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Flu Vaccine Sales Forecast by Type (2017-2022)
11.7 EMEA Flu Vaccine Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Flu Vaccine
Figure EMEA Flu Vaccine Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Flu Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Whole Virus Vaccines Product Picture
Figure Split Virus Vaccines Product Picture
Figure Subunit Or Surface Antigen Vaccines Product Picture
Figure Live Attenuated (Cold-Adapted) Virus Vaccines Product Picture
Figure EMEA Flu Vaccine Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Flu Vaccine by Application in 2016
Figure For Children (6 months to 3 years old) Examples
Table Key Downstream Customer in For Children (6 months to 3 years old)
Figure For Adult and Children over 3 years Examples
Table Key Downstream Customer in For Adult and Children over 3 years
Figure EMEA Flu Vaccine Market Size (Million USD) by Region (2012-2022)
Figure Europe Flu Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Flu Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Flu Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Flu Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Africa Flu Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Flu Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Flu Vaccine Sales Volume and Growth Rate (2012-2022)
Figure EMEA Flu Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Flu Vaccine Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Flu Vaccine Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Flu Vaccine Sales Share by Players (2012-2017)
Figure 2016 Flu Vaccine Sales Share by Players
Figure 2017 Flu Vaccine Sales Share by Players
Figure EMEA Flu Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Flu Vaccine Revenue (Million USD) by Players (2012-2017)
Table EMEA Flu Vaccine Revenue Share by Players (2012-2017)
Table 2016 EMEA Flu Vaccine Revenue Share by Players
Table 2017 EMEA Flu Vaccine Revenue Share by Players
Table EMEA Flu Vaccine Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Flu Vaccine Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Flu Vaccine Sales Share by Type (2012-2017)
Figure Sales Market Share of Flu Vaccine by Type (2012-2017)
Figure EMEA Flu Vaccine Sales Market Share by Type (2012-2017)
Table EMEA Flu Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Flu Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Flu Vaccine by Type in 2016
Table EMEA Flu Vaccine Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Flu Vaccine Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Flu Vaccine Sales Share by Application (2012-2017)
Figure Sales Market Share of Flu Vaccine by Application (2012-2017)
Figure EMEA Flu Vaccine Sales Market Share by Application in 2016
Table EMEA Flu Vaccine Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Flu Vaccine Sales Share by Region (2012-2017)
Figure Sales Market Share of Flu Vaccine by Region (2012-2017)
Figure EMEA Flu Vaccine Sales Market Share in 2016
Table EMEA Flu Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Flu Vaccine Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Flu Vaccine by Region (2012-2017)
Figure EMEA Flu Vaccine Revenue Market Share Regions in 2016
Table EMEA Flu Vaccine Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Flu Vaccine Revenue and Growth Rate (2012-2017)
Table Europe Flu Vaccine Sales (K Pcs) by Type (2012-2017)
Table Europe Flu Vaccine Market Share by Type (2012-2017)
Figure Europe Flu Vaccine Market Share by Type in 2016
Table Europe Flu Vaccine Sales (K Pcs) by Application (2012-2017)
Table Europe Flu Vaccine Market Share by Application (2012-2017)
Figure Europe Flu Vaccine Market Share by Application in 2016
Table Europe Flu Vaccine Sales (K Pcs) by Countries (2012-2017)
Table Europe Flu Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Flu Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Flu Vaccine Sales Market Share by Countries in 2016
Table Europe Flu Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Europe Flu Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Flu Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Flu Vaccine Revenue Market Share by Countries in 2016
Figure Germany Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Flu Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Flu Vaccine Sales (K Pcs) by Type (2012-2017)
Table Middle East Flu Vaccine Market Share by Type (2012-2017)
Figure Middle East Flu Vaccine Market Share by Type (2012-2017)
Table Middle East Flu Vaccine Sales (K Pcs) by Applications (2012-2017)
Table Middle East Flu Vaccine Market Share by Applications (2012-2017)
Figure Middle East Flu Vaccine Sales Market Share by Application in 2016
Table Middle East Flu Vaccine Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Flu Vaccine Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Flu Vaccine Sales Volume Market Share by Countries in 2016
Table Middle East Flu Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Middle East Flu Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Flu Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Flu Vaccine Revenue Market Share by Countries in 2016
Figure Saudi Arabia Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Flu Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Flu Vaccine Sales (K Pcs) by Type (2012-2017)
Table Africa Flu Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Flu Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Flu Vaccine Sales Market Share by Type in 2016
Table Africa Flu Vaccine Sales (K Pcs) by Application (2012-2017)
Table Africa Flu Vaccine Sales Market Share by Application (2012-2017)
Figure Africa Flu Vaccine Sales Market Share by Application (2012-2017)
Table Africa Flu Vaccine Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Flu Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Flu Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Flu Vaccine Sales Market Share by Countries in 2016
Table Africa Flu Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Africa Flu Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Flu Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Flu Vaccine Revenue Market Share by Countries in 2016
Figure South Africa Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Table Sanofi-pasteur Flu Vaccine Basic Information List
Table Sanofi-pasteur Flu Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi-pasteur Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sanofi-pasteur Flu Vaccine Sales Market Share in EMEA (2012-2017)
Figure Sanofi-pasteur Flu Vaccine Revenue Market Share in EMEA (2012-2017)
Table Novartis Flu Vaccine Basic Information List
Table Novartis Flu Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Novartis Flu Vaccine Sales Market Share in EMEA (2012-2017)
Figure Novartis Flu Vaccine Revenue Market Share in EMEA (2012-2017)
Table GSK Flu Vaccine Basic Information List
Table GSK Flu Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GSK Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure GSK Flu Vaccine Sales Market Share in EMEA (2012-2017)
Figure GSK Flu Vaccine Revenue Market Share in EMEA (2012-2017)
Table Abbott Flu Vaccine Basic Information List
Table Abbott Flu Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Abbott Flu Vaccine Sales Market Share in EMEA (2012-2017)
Figure Abbott Flu Vaccine Revenue Market Share in EMEA (2012-2017)
Table Pfizer Flu Vaccine Basic Information List
Table Pfizer Flu Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Flu Vaccine Sales Market Share in EMEA (2012-2017)
Figure Pfizer Flu Vaccine Revenue Market Share in EMEA (2012-2017)
Table CSL Flu Vaccine Basic Information List
Table CSL Flu Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure CSL Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure CSL Flu Vaccine Sales Market Share in EMEA (2012-2017)
Figure CSL Flu Vaccine Revenue Market Share in EMEA (2012-2017)
Table Hualan Bio Flu Vaccine Basic Information List
Table Hualan Bio Flu Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Hualan Bio Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Hualan Bio Flu Vaccine Sales Market Share in EMEA (2012-2017)
Figure Hualan Bio Flu Vaccine Revenue Market Share in EMEA (2012-2017)
Table Changchun Bio Flu Vaccine Basic Information List
Table Changchun Bio Flu Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Changchun Bio Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Changchun Bio Flu Vaccine Sales Market Share in EMEA (2012-2017)
Figure Changchun Bio Flu Vaccine Revenue Market Share in EMEA (2012-2017)
Table Alephbio Flu Vaccine Basic Information List
Table Alephbio Flu Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Alephbio Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Alephbio Flu Vaccine Sales Market Share in EMEA (2012-2017)
Figure Alephbio Flu Vaccine Revenue Market Share in EMEA (2012-2017)
Table Sinovac Flu Vaccine Basic Information List
Table Sinovac Flu Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sinovac Flu Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sinovac Flu Vaccine Sales Market Share in EMEA (2012-2017)
Figure Sinovac Flu Vaccine Revenue Market Share in EMEA (2012-2017)
Table CS Vaccine Flu Vaccine Basic Information List
Table Tianyuan Bio Flu Vaccine Basic Information List
Table Tiantan Bio Flu Vaccine Basic Information List
Table Siobp Flu Vaccine Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Flu Vaccine
Figure Manufacturing Process Analysis of Flu Vaccine
Figure Flu Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Flu Vaccine Major Manufacturers in 2016
Table Major Buyers of Flu Vaccine
Table Distributors/Traders List
Figure EMEA Flu Vaccine Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Flu Vaccine Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Flu Vaccine Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Flu Vaccine Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Flu Vaccine Sales Market Share Forecast by Region (2017-2022)
Table EMEA Flu Vaccine Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Flu Vaccine Revenue Market Share Forecast by Region (2017-2022)
Table Europe Flu Vaccine Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Flu Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Europe Flu Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Flu Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Flu Vaccine Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Flu Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Flu Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Flu Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Flu Vaccine Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Flu Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Africa Flu Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Flu Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Flu Vaccine Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Flu Vaccine Sales Market Share Forecast by Type (2017-2022)
Table EMEA Flu Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Flu Vaccine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *